Related Experiment Video

Updated: Apr 17, 2026

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
10:09

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark

Published on: January 26, 2018

8.0K

Liver histone H3 methylation and acetylation may associate with type 2 diabetes development

Peipei Tu1, Xiaodan Li, Baicheng Ma

  • 1College of Life Sciences, Nankai University, Nankai,, Tianjin, China, tupeipei_2008@163.com.

Journal of Physiology and Biochemistry
|February 11, 2015
PubMed

Insights

Histone modifications in the liver are linked to type 2 diabetes (T2D) progression. Exendin-4 treatment altered these epigenetic marks, suggesting potential new strategies for T2D prevention.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Endocrinology

Background:

  • Type 2 diabetes (T2D) pathogenesis involves complex molecular mechanisms.
  • Histone modifications, crucial regulators of gene expression, have roles in various diseases, but their specific involvement in diabetes remains largely unexplored.

Purpose of the Study:

  • To investigate the association between specific histone modifications in the liver and the development of T2D.
  • To evaluate the impact of exendin-4, a T2D treatment, on these histone modifications.

Main Methods:

  • A T2D mouse model was established and treated with exendin-4.
  • Western blotting was used to analyze histone modifications (H3K9ac, H3K23ac, H3K4me1, H3K9me2) in liver histone extracts.
  • Real-time PCR and Chromatin Immunoprecipitation (ChIP) were employed to assess gene expression and histone modifications at the Glut2 promoter.

Main Results:

  • Diabetic mice exhibited increased liver H3K4 monomethylation and H3K9 dimethylation, which were normalized by exendin-4.
  • H3K9 and H3K23 acetylation levels were decreased in diabetic mice; exendin-4 partially restored H3K9 acetylation.
  • Global liver histone modifications, including H3K9/H3K23 acetylation, H3K4 monomethylation, and H3K9 dimethylation, correlated with T2D progression.

Conclusions:

  • Liver histone modifications are significantly associated with type 2 diabetes mellitus progression.
  • Targeting histone-modifying enzymes could offer novel therapeutic strategies for preventing or treating T2D.

More Related Videos

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.6K
Global Level Quantification of Histone Post-Translational Modifications in a 3D Cell Culture Model of Hepatic Tissue08:12

Global Level Quantification of Histone Post-Translational Modifications in a 3D Cell Culture Model of Hepatic Tissue

Published on: May 5, 2022

4.6K

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
2
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
17.8K
Histone Modification02:32

Histone Modification

5.0K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
1
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.5K